Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II melatonin study for sleep architecture in children with autism
2013-001230-17Phase 2Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of melatonin in Autism Spectrum Disorder (ASD), sponsored by Hospices Civils de Lyon. Started Sep 2015; status: completed.
02
Drugs
melatonin
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on 2013-001230-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001230-17.